Crossject (France) Today
| ALCJ Stock | EUR 1.98 0.03 1.54% |
Performance0 of 100
| Odds Of DistressLess than 12
|
Crossject is trading at 1.98 as of the 24th of November 2024, a 1.54 percent up since the beginning of the trading day. The stock's open price was 1.95. Crossject has less than a 12 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Crossject are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of October 2024 and ending today, the 24th of November 2024. Click here to learn more.
Crossject Socit Anonyme develops needle-free injection systems. The company was founded in 1997 and is based in Dijon, France. CROSSJECT is traded on Paris Stock Exchange in France. The company has 34.9 M outstanding shares. More on Crossject
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Crossject Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Crossject's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Crossject or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Patrick Alexandre |
| Business Concentration | Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) |
Crossject (ALCJ) is traded on Euronext Paris in France and employs 96 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 168.21 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Crossject's market, we take the total number of its shares issued and multiply it by Crossject's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Crossject operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 34.9 M outstanding shares.
Crossject has accumulated about 154 K in cash with (6.08 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.35.
Check Crossject Probability Of Bankruptcy
Ownership AllocationCrossject holds a total of 34.9 Million outstanding shares. Crossject retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Crossject Ownership Details
Crossject Risk Profiles
Although Crossject's alpha and beta are two of the key measurements used to evaluate Crossject's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.42 | |||
| Standard Deviation | 3.23 | |||
| Variance | 10.4 | |||
| Risk Adjusted Performance | (0.04) |
Crossject Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Crossject without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
Other Information on Investing in Crossject Stock
Crossject financial ratios help investors to determine whether Crossject Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Crossject with respect to the benefits of owning Crossject security.